Earnings History Data for Xeris Biopharma Holdings, Inc. (XERS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings is a biopharmaceutical company. It involved in developing and commercializing therapies for patient in endocrinology, neurology and gastroenterology. The company's principal product includes Gvoke(R), a ready-to-use liquid glucagon for the treatment of severe hypoglycemia and Keveyis(R), the first and only FDA-approved therapy for primary periodic paralysis. Xeris Biopharma Holdings, formerly known as Xeris Pharmaceuticals Inc., is headquartered in Chicago, IL.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-08-2025	PM		XERS	Xeris Biopharma Holdings, Inc.	877.65	-0.01	-0.03	-0.10	Xeris Pharmaceuticals GAAP EPS of -$0.01 beats by $0.02, revenue of $71.5M beats by $6.92M [8/7/2025 7:08 AM]	6.59	1.10 (20.04%)	6.56	1.07 (19.49%)	2.10 - 7.09	9,099,435	2,100,000	504,634
Xeris Pharmaceuticals Q2 2025 Earnings Preview [8/6/2025 12:14 PM] Xeris Pharmaceuticals GAAP EPS of -$0.01 beats by $0.02, revenue of $71.5M beats by $6.92M [8/7/2025 7:08 AM] Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance [2025-08-07 07:00AM]
08-05-2025	PM		XERS	Xeris Biopharma Holdings, Inc.	661.94	-0.06	-0.07	-0.14	Xeris Pharmaceuticals beats top-line and bottom-line estimates; narrows FY25 outlook [5/8/2025 7:07 AM]	5.15	0.66 (14.84%)	4.52	0.04 (0.89%)	1.72 - 6.07	4,558,399	2,170,000	158,431
Xeris Pharmaceuticals Q1 2025 Earnings Preview [5/7/2025 12:08 PM] Xeris Pharmaceuticals beats top-line and bottom-line estimates; narrows FY25 outlook [5/8/2025 7:07 AM] Xeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev growth [5/8/2025 2:16 PM] Xeris Biopharma Reports Record First Quarter 2025 Financial Results [2025-05-08 07:00AM] Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings [May-07-25 11:51AM]
06-03-2025	PM		XERS	Xeris Pharmaceuticals	550.00	-0.03	-0.07	0.00	Xeris Pharmaceuticals beats top-line and bottom-line estimates; initiates FY25 outlook [3/6/2025 7:02 AM]	4.12	0.35 (9.28%)	4.09	0.32 (8.49%)	1.69 - 4.50	8,886,108	1,760,000	258,615
Xeris Pharmaceuticals Q4 2024 Earnings Preview [3/5/2025 12:46 PM] Xeris Pharmaceuticals beats top-line and bottom-line estimates; initiates FY25 outlook [3/6/2025 7:02 AM] Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance [2025-03-06 07:00AM]
08-11-2024	PM		XERS	Xeris Biopharma Holdings, Inc.	497.66	-0.06	-0.09	-0.09	Xeris Pharmaceuticals GAAP EPS of -$0.11 misses by $0.02, revenue of $54.3M beats by $2.87M [11/8/2024 7:11 AM]	3.44	0.08 (2.23%)	3.40	0.04 (1.19%)	1.46 - 3.64	6,249,088	1,540,000	121,510
Xeris Pharmaceuticals Q3 2024 Earnings Preview [11/7/2024 12:06 PM] Xeris Pharmaceuticals GAAP EPS of -$0.11 misses by $0.02, revenue of $54.3M beats by $2.87M [11/8/2024 7:11 AM] Xeris Biopharma Reports Third Quarter 2024 Financial Results [2024-11-08 07:00AM]
08-08-2024	PM		XERS	Xeris Biopharma Holdings, Inc.	335.06	-0.10	-0.11	-0.14	Xeris Pharmaceuticals GAAP EPS of -$0.10 beats by $0.01, revenue of $48.07M beats by $2.26M [8/8/2024 7:11 AM]	2.20	0.07 (3.29%)	2.18	0.05 (2.35%)	1.46 - 3.26	2,920,180	1,420,000	41,884
Xeris Pharmaceuticals Q2 2024 Earnings Preview [8/7/2024 11:03 AM] Xeris Biopharma GAAP EPS of -$0.10 beats by $0.01, revenue of $48.07M beats by $2.26M [8/8/2024 7:11 AM]
09-05-2024	PM		XERS	Xeris Biopharma Holdings, Inc.	264.05	-0.14	-0.12	-0.12	Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.02, revenue of $40.64M misses by $1.17M [5/9/2024 7:16 AM]	1.87	0.02 (1.08%)	1.80	-0.05 (-2.70%)	1.46 - 3.26	1,466,686	1,050,000	29,752
Xeris Pharmaceuticals Q1 2024 Earnings Preview [5/8/2024 11:41 AM] Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.02, revenue of $40.64M misses by $1.17M [5/9/2024 7:16 AM]
06-03-2024	PM		XERS	Xeris Biopharma Holdings, Inc.	439.24	-0.10	-0.09	-0.10	Xeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84M [3/6/2024 7:03 AM]	2.48	-0.60 (-19.64%)	3.02	-0.06 (-1.95%)	1.13 - 3.26	7,904,083	2,210,000	266,190
Xeris Pharmaceuticals Q4 2023 Earnings Preview [3/5/2024 11:52 AM] Xeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84M [3/6/2024 7:03 AM]
09-11-2023	PM		XERS	Xeris Biopharma Holdings, Inc.	258.87	-0.09	-0.12	-0.14	Xeris Pharmaceuticals GAAP EPS of -$0.09 beats by $0.03, revenue of $48.32M beats by $7.24M [11/9/2023 7:03 AM]	1.80	-0.18 (-8.84%)	2.03	0.05 (2.53%)	0.97 - 3.07	2,907,507	930,000	93,305
Xeris Pharmaceuticals Q3 2023 Earnings Preview [11/8/2023 12:51 PM] Xeris Pharmaceuticals GAAP EPS of -$0.09 beats by $0.03, revenue of $48.32M beats by $7.24M [11/9/2023 7:03 AM]
08-08-2023	PM		XERS	Xeris Biopharma Holdings, Inc.	362.50	-0.14	-0.13	-0.19	Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.01, revenue of $38.01M beats by $3.17M [8/8/2023 7:06 AM]	2.58	0.09 (3.82%)	2.41	-0.08 (-3.21%)	0.97 - 3.07	1,593,495	930,000	57,522
Xeris Pharmaceuticals Q2 2023 Earnings Preview [8/7/2023 1:39 PM] Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.01, revenue of $38.01M beats by $3.17M [8/8/2023 7:06 AM]
09-05-2023	PM	7:00 AM ET (May 9)	XERS	Xeris Pharmaceuticals	0.00	-0.12	-0.17	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.12 beats by $0.05, revenue of $33.2M beats by $2.43M [5/9/2023 7:03 AM]	2.73	0.33 (13.54%)	2.44	0.04 (1.67%)	0.97 - 2.73	3,107,337	1,130,000	41,234
Xeris Pharmaceuticals Q1 2023 Earnings Preview [5/8/2023 12:35 PM] Xeris Pharmaceuticals GAAP EPS of -$0.12 beats by $0.05, revenue of $33.2M beats by $2.43M [5/9/2023 7:03 AM]
08-03-2023	PM	7:00 AM ET (Mar 8)	XERS	Xeris Pharmaceuticals	0.00	-0.10	-0.16	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.10 beats by $0.06, revenue of $32.54M beats by $1.5M [3/8/2023 6:25 AM]	1.35	-0.18 (-11.76%)	1.45	-0.08 (-5.23%)	0.97 - 2.95	1,723,231	1,180,000	108,007
Xeris Pharmaceuticals GAAP EPS of -$0.10 beats by $0.06, revenue of $32.54M beats by $1.5M [3/8/2023 6:25 AM] Xeris stock falls ~10% despite revenue growth, narrowed loss in Q4 [3/8/2023 11:22 AM]
09-11-2022	PM	7:00 AM ET (Nov 9)	XERS	Xeris Pharmaceuticals	0.00	-0.14	-0.17	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01, revenue of $29.6M beats by $0.48M [11/9/2022 7:11 AM]	1.49	-0.01 (-0.67%)	1.59	0.09 (6.00%)	1.19 - 3.17	893,368	490,000	37,920
Xeris Pharmaceuticals Q3 2022 Earnings Preview [11/8/2022 1:04 PM] Xeris Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01, revenue of $29.6M beats by $0.48M [11/9/2022 7:11 AM] Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events [Nov-09-22 07:00AM]
10-08-2022	PM	7:00 AM ET (Aug 10)	XERS	Xeris Pharmaceuticals	0.00	-0.19	-0.23	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.19 beats by $0.04, revenue of $25.31M misses by $0.22M [8/10/2022 7:04 AM]	1.92	0.22 (12.94%)	1.74	0.04 (2.35%)	1.25 - 3.17	1,347,041	840,000	27,213
Xeris Pharmaceuticals Q2 2022 Earnings Preview [8/9/2022 1:15 PM] Xeris Pharmaceuticals GAAP EPS of -$0.19 beats by $0.04, revenue of $25.31M misses by $0.22M [8/10/2022 7:04 AM] Xeris Pharmaceuticals net loss narrows as Q2 results beat on bottom line [8/10/2022 7:56 AM]
11-05-2022	PM	7:00 AM ET (May 11)	XERS	Xeris Pharmaceuticals	0.00	-0.25	-0.24	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.25 in-line, net product revenue of $21.91M misses by $1.48M [5/11/2022 7:06 AM]	1.65	-0.14 (-8.10%)	1.89	0.10 (5.59%)	1.54 - 4.98	2,554,378	1,620,000	11,061
Xeris Pharmaceuticals Q1 2022 Earnings Preview [5/10/2022 12:17 PM] Xeris Pharmaceuticals GAAP EPS of -$0.25 in-line, net product revenue of $21.91M misses by $1.48M [5/11/2022 7:06 AM] Xeris stock falls 8% after missing Q1 revenue estimates [5/11/2022 11:19 AM] Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events [May-11-22 07:00AM]
10-03-2022	PM	7:00 AM ET (Mar 10)	XERS	Xeris Pharmaceuticals	0.00	-0.42	-0.21	0.00	Xeris Pharmaceuticals GAAP EPS of -$0.42 misses by $0.14, net product revenue of $21.36M [3/10/2022 7:06 AM]	2.46	-0.02 (-0.61%)	2.34	-0.13 (-5.26%)	1.77 - 5.09	1,475,590	3,108,270	0
Xeris Pharmaceuticals Q4 2021 Earnings Preview [3/9/2022 1:59 PM] Xeris Pharmaceuticals GAAP EPS of -$0.42 misses by $0.14, net product revenue of $21.36M [3/10/2022 7:06 AM] Xeris Biopharma receives $150M in senior secured term loan facility with Hayfin Capital [3/10/2022 7:17 AM] Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events [Mar-10-22 07:00AM] Xeris Announces $150M Senior Secured Term Loan Facility With Hayfin Capital [Mar-10-22 06:55AM]
05-08-2021	PM	7:00 AM ET (Aug 5)	XERS	Xeris Pharmaceuticals, Inc.	196.83	-0.41	-0.31	-0.63	Xeris Pharmaceuticals EPS misses by $0.14, misses on revenue [8/5/2021 7:08 AM]	2.48	-0.37 (-12.98%)	2.48	0.0 (0.00%)	2.20 - 7.94	6,615,225	1,180,000	300
Xeris Pharmaceuticals EPS misses by $0.14, misses on revenue [8/5/2021 7:08 AM] Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights [Aug-05-21 07:00AM] Xeris Pharmaceuticals (XERS) Reports Q2 Loss, Misses Revenue Estimates [Aug-05-21 09:15AM]
13-05-2021	PM	7:00 AM ET (May 13)	XERS	Xeris Pharmaceuticals, Inc.	226.86	-0.30	-0.31	-0.89	Xeris Pharmaceuticals EPS beats by $0.06, beats on revenue [5/13/2021 7:06 AM]	3.19	-0.14 (-4.20%)	3.19	0.0 (0.00%)	2.45 - 7.94	3,954,871	2,160,000	23,548
Xeris Pharmaceuticals EPS beats by $0.06, beats on revenue [5/13/2021 7:06 AM] Xeris Pharmaceuticals Reports First Quarter 2021 Financial Results and Recent Highlights [May-13-21 07:00AM] Xeris Pharmaceuticals (XERS) Reports Q1 Loss, Tops Revenue Estimates [May-13-21 12:11PM]
09-03-2021	PM	7:00 AM ET (Mar 9)	XERS	Xeris Pharmaceuticals, Inc.	237.05	-0.41	-0.39	-1.23	Xeris Pharmaceuticals EPS misses by $0.01, misses on revenue [3/9/2021 7:03 AM]	4.57	-0.15 (-3.18%)	4.33	-0.39 (-8.26%)	1.42 - 7.94	4,590,862	2,518,324	142,673
Xeris Pharmaceuticals EPS misses by $0.01, misses on revenue [3/9/2021 7:03 AM] Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights [Mar-09-21 07:00AM] Earnings Outlook for Xeris Pharmaceuticals [Mar-08-21 10:14AM] Xeris Pharmaceuticals (XERS) Reports Q4 Loss, Misses Revenue Estimates [Mar-09-21 08:15AM]
09-11-2020	PM	7:00 AM ET (Nov 9)	XERS	Xeris Pharmaceuticals, Inc.	250.38	-0.35	-0.54	-1.22	Xeris Pharmaceuticals EPS beats by $0.19, beats on revenue [11/9/2020 7:25 AM]	5.72	0.27 (4.95%)	5.98	0.53 (9.72%)	1.42 - 9.69	2,481,513	1,294,694	207,316

10-08-2020	PM	7:00 AM ET (Aug 10)	XERS	Xeris Pharmaceuticals, Inc.	147.54	-0.63	-0.71	-1.28	Xeris Pharmaceuticals EPS beats by $0.09, beats on revenue [8/10/2020 7:03 AM]	3.50	0.16 (4.63%)	3.49	0.14 (4.18%)	1.42 - 12.50	3,438,005	2,867,491	321,785